IL6 and Alzheimer disease: By reducing LDL-C levels, lowering immune cell activation and T-cell exhaustion, and conferring a reduction in IL-6 in participants with elevated inflammation, the AD could serve as a powerful tool in reducing metabolic and immune dysfunction in PLWH.